Laurion Capital Management LP - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 56 filers reported holding CARDIFF ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 18.62 and the average weighting 0.0%.

Quarter-by-quarter ownership
Laurion Capital Management LP ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q3 2023$1,003,719
-5.4%
722,1000.0%0.01%0.0%
Q2 2023$1,061,487
-10.9%
722,1000.0%0.01%
-25.0%
Q1 2023$1,191,465
+17.9%
722,1000.0%0.01%
+60.0%
Q4 2022$1,010,940
-9.1%
722,1000.0%0.01%
-28.6%
Q3 2022$1,112,000
-30.0%
722,1000.0%0.01%
-72.0%
Q2 2022$1,589,000722,1000.02%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
ELKHORN PARTNERS LIMITED PARTNERSHIP 45,000$630.04%
FinDec Wealth Services, Inc. 16,000$22,2400.02%
DENVER WEALTH MANAGEMENT, INC. 18,235$25,3470.02%
Atom Investors LP 18,298$25,4340.01%
Laurion Capital Management LP 722,100$1,003,7190.01%
MAI Capital Management 224,749$312,4010.01%
Callan Capital, LLC 31,147$43,2940.01%
GSA CAPITAL PARTNERS LLP 25,975$360.00%
Tortoise Investment Management, LLC 15,000$20,8500.00%
America First Investment Advisors, LLC 4,000$5,5600.00%
View complete list of CARDIFF ONCOLOGY INC shareholders